Jonathan Thompson, MD, MS, explains that adjuvant immunotherapy benefits patients with early-stage lung cancer with incomplete neoadjuvant response, while treatment decisions in the adjuvant ...

With the FDA approval of its zongertinib in certain non-small cell lung cancer (NSCLC) patients, 175-year-old Boehringer Ingelheim is entering the oncology market. | Zongertinib got an accelerated ...

Using genetic screening, scientists have found a new drug combination that works against some treatment-resistant lung, brain and pancreatic cancers.

Breakthrough lung cancer treatment supercharges immune cells with mitochondria Date: August 3, 2025 Source: China Anti-Cancer Association Summary: Scientists have found a way to supercharge lung ...

Friday is World Lung Cancer Day and the hope is to bring attention to risk factors, as well as the importance of early detection.

Cannabis and Lung Cancer Pradère referenced a well-known study published in Chest in 2018, which suggested that smoking cannabis does not cause emphysema or impair inspiratory function.

An international study found that air pollution leads to more cancer-related genetic changes than secondhand smoke.

SNMMI image of the year: New immuno-pet tracer superior to FDG PET in predicting PD-L1 expression in head and neck cancer ...

Fortunately, advancements in artificial intelligence (AI) are transforming lung cancer screening, improving both accuracy and efficiency.

Master regulator blocking immunotherapy, paving the way for a new lung cancer treatment Date: April 9, 2025 Source: The Korea Advanced Institute of Science and Technology (KAIST) Summary ...

Scientists from the Francis Crick Institute, UCL, UCLH and Personalis have found that a test to detect circulating tumor DNA can predict lung cancer outcome in a Cancer Research UK-funded study.

The International Association for the Study of Lung Cancer & Lung Cancer Research Foundation award first $2.5 million team science grant to advance lung cancer cure Four-year grant supports global ...